Evidence map›Paper›PMID 40171703›Full record

ArticleActa dermato-venereologica2025

Impact on Major Life-changing Decisions in Patients with Atopic Dermatitis.

Lucia Fuentes-Barragán, Carmen García-Moronta, Raquel Sanabria-de la Torre, Francisco Javier León-Pérez, Alejandro Molina-Leyva, Salvador Arias-Santiago, Trinidad Montero-Vílchez

Abstract read
In one paragraph

Article in Acta dermato-venereologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lucia Fuentes-BarragánUniversity of Granada, Granada, Spain.
Carmen García-MorontaDepartment of Dermatology, University Hospital Virgen de las Nieves, Granada, Spain.
Raquel Sanabria-de la TorreUniversity of Granada, Granada, Spain; Biosanitary Research Institute of Granada, Granada, Spain.
Francisco Javier León-PérezDepartment of Dermatology, University Hospital Virgen de las Nieves, Granada, Spain.
Alejandro Molina-LeyvaDepartment of Dermatology, University Hospital Virgen de las Nieves, Granada, Spain.
Salvador Arias-SantiagoUniversity of Granada, Granada, Spain; Department of Dermatology, University Hospital Virgen de las Nieves, Granada, Spain; Biosanitary Research Institute of Granada, Granada, Spain. salvadorarias@ugr.es.
Trinidad Montero-VílchezDepartment of Dermatology, University Hospital Virgen de las Nieves, Granada, Spain; Biosanitary Research Institute of Granada, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis (AD) is a chronic skin disease that significantly affects patients' quality of life. While other dermatological conditions like psoriasis are known to impact major life-changing decisions (MLCD), no prior studies have evaluated this in AD. A descriptive cross-sectional study was conducted in patients with AD of at least 6 months' duration. Sociodemographic and clinical characteristics of the patients, as well as severity from both the physician's and patient's point of view, were assessed using different rating scales such as the Eczema Area and Severity Index (EASI). Subsequently, patients were divided according to disease severity into severe AD (EASI ≥ 21) or mild-moderate AD (EASI < 21). Life decisions were evaluated across several areas, including work, education, social life, reproduction, recreation, housing, and lifestyle, using a 4-point Likert scale. A total of 104 patients, with an average disease duration of 20.36 years, were included. The results showed significant MLCD impairment, especially in clothing choices (52.9%), lifestyle (48.1%), and sports activities (41.4%). Severe AD was associated with greater social and emotional challenges, such as difficulties in social interactions (48.6% vs 26.1%) and romantic relationships (48.5% vs 18.8%) compared with mild-moderate AD. These findings highlight the profound impact of AD on daily life, emphasizing the need for comprehensive management strategies that address physical, psychological, and social aspects.

Indexed as

Cost of IllnessDecision MakingDermatitis, AtopicLife StyleQuality of LifeAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedSeverity of Illness IndexTime FactorsYoung Adult

Identifiers

PMID40171703
PMCPMC11977411

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.